“There’s More to Neuropathy than Numbness, Weakness, Tingling, and Pain" Facebook Chat on August 28th Draws Hundreds, Raises Awareness of Neuropathy's Scope

September 13, 2013

On August 28th, Drs. Jaydeep Bhatt, Myrna Cardiel, and William Schwieterman hosted a “chat” event on The Neuropathy Association’s Facebook page aimed at helping us better understand how neuropathy affects us—from head to toe. This educational, and awareness-building, Chat event drew several hundred participants on Facebook for a much-needed global conversation on neuropathy. 

Facebook Chat Image - Association Logo
Missed this Facebook Chat? Get
your free copy of the transcript
once it is published by signing up 
for email alerts from The Neuropathy

Related articles:

- Understanding Neuropathy’s

- “Ask the Doctor” column: Autonomic

- Understanding Neuropathic Pain

- What Do Depression, Anxiety, and
Sleep Disturbances Have To Do
With Neuropathy?

- Could Dizziness, Lightheadedness,
and Fainting Be Linked to

Support Your #1 Cause: Beat 

Closing Bell Honors Millions With
Neuropathy and Neuropathic Pain

From head to toe, every part of the human body contains peripheral nerves. So, peripheral neuropathy can be a “whole body” experience, involving a range of symptoms that you may -- or may not -- recognize as part of your neuropathy. Neuropathy’s symptoms vary depending on where the nerve damage is occurring in the body. It also varies depending on what type of peripheral nerves -- motor, sensory, and autonomic that connect the spinal cord to the muscles, skin, blood vessels, and internal organs -- are involved.

Ongoing education, communication, and support are important tools to work with when neuropathy affects both you and your loved ones. Using these tools improves a family’s ability to work together to manage the day-to-day aspects of living with a chronic disease like neuropathy.

Drs. Bhatt, Cardiel, and Schwieterman will field questions posed by the Chat participants while also discussing the importance of recognizing the varying symptoms of neuropathy. The Chats offer participants a chance to hear from and ask questions of their peers — patients and caregivers — who are battling neuropathy. The Chats also emphasize that living well with neuropathy is possible with early diagnosis, symptom management, and regular follow-ups, but it requires active engagement by the patient in his/her own medical care along with the aid of an array of resources — limited as they are — that do currently exist.

Dr. Jaydeep Bhatt is an assistant professor of Neurology at New York University School of Medicine. Dr. Bhatt is board certified in Neurology and Electrodiagnostic Medicine and has a clinical and academic subspecialty in neuromuscular disorders including peripheral and entrapment neuropathies, myopathies, motor neuron disease, and myasthenia gravis.

Dr. Myrna Cardiel is a clinical assistant professor of Neurology at New York University School of Medicine. Dr. Cardiel completed a clinical neurophysiology fellowship at NYU. Previously, she practiced general neurology while on active military service in the United States Army, where she held the rank of Major. Dr. Cardiel completed her internship and residency training in neurology at Walter Reed Army Medical Center, the National Naval Medical Center, and the Uniformed Services University of the Health Sciences. She has published several papers on entrapment neuropathies. She is board certified in Neurology and Electrodiagnostic Medicine.

Dr. William D. Schwieterman is Chief Medical Officer at Chelsea Therapeutics. Chelsea Therapeutics is a development stage biopharmaceutical company located in Charlotte, North Carolina.  Chelsea is currently pursuing FDA approval in the U.S. for Northera™ (droxidopa), a novel, late-stage, orally-active therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension resulting from various neurodegenerative diseases, including Parkinson’s disease, multiple system atrophy and pure autonomic failure. After graduating from the University of Cincinnati College of Medicine and completing his residency in Internal Medicine at the Mt Sinai Hospital (New York City) and fellowship in rheumatology at the National Institutes of Arthritis and Musculoskeletal Skin Disease (NIAMS), respectively, Dr. Schwieterman joined the Food and Drug Administration in 1992.  There he spent 10 years within the Center for Biologics, where he reviewed and supervised the development of numerous investigational biotech agents for the development of a wide range of diseases. 

A special thanks to Drs. Bhatt, Cardiel, and Schwieterman for giving their time and expertise to speak with our community!

P.S. If you do not use Facebook:

- You can still access the Chat "live" by visiting The Neuropathy Association's Facebook page, but you will not be able to join the conversation by posting comments. View the Association's Facebook page!

- You can read a transcript of the highlights from the Chat that will be published afterwards in the coming weeks. Sign up to receive your free copy of the transcript by email!



All active news articles

Home / Contact UsPeripheral Neuropathy Site Map / Disclaimer
© 2015 The Neuropathy Association / 110 W. 40th Street, Suite 1804 / New York, NY 10018 / 212-692-0662


- +